This video was published 642 Days 10 Hours 39 Mins ago.
Member Access: Available NOW Public Access: Available NOW
THE 3 MINUTE PRESS SHOW with Tracee Tolentino
Discover the News behind the News from today's leading executives. Each day we interview the leading Executives on the press of that day.
The 3 Minute Press Show gives you the:
Who, What, Where, When, Why and How of this Press and how it will impact the company and its shareholders.
Members are encouraged to ask these executives questions through their message boards at Mywallst
Opexa Therapeutics develops and commercializes cell therapies to treat autoimmune diseases such as MS, rheumatoid arthritis, and diabetes. The Company is focused on autologous cellular therapy applications of its proprietary T-cell and stem cell therapies. The Company's lead product, Tovaxin, a T-cell therapy for multiple sclerosis is in Phase IIb trials. The Company holds the exclusive worldwide license for adult multipotent stem cells derived from mononuclear cells of peripheral blood. The technology allows large quantities of monocyte derived stem cells to be produced efficiently for use in autologous therapy, thus circumventing the threat of rejection. The Company is in preclinical development for diabetes mellitus. For more information, visit the Opexa Therapeutics website at www.opexatherapeutics.com.
User Comments
0 Bulls
0 Bears
Be the first to comment on Opexa Therapeutics, Inc (NASDAQ: OPXA)
General Electric Company (GE) operates as a technology, media, and financial services company worldwide. It operates through four segments: GE Capital, Energy Infrastructure, Technology Infrastructure…
Founded in 1960, Domino's Pizza is the recognized world leader in pizza delivery. Through its primarily locally-owned and operated franchised system, Domino's operates a network of 8,726 franchised and…
Starwood Hotels & Resorts Worldwide, Inc., together with its subsidiaries, operates as a hotel and leisure company worldwide. It primarily operates luxury and upscale full service hotels, retreats, and…